Evaxion and ExpreS²ion partner to develop new CMV vaccine
06 Dec 2022 //
PHARMACEUTICAL-TECHNOLOGY
First subject vaccinated in COVID-19 Phase III clinical trial for ABNCoV2
02 Sep 2022 //
CISION
06 Dec 2022 //
PHARMACEUTICAL-TECHNOLOGY
02 Sep 2022 //
CISION